Touchstone International Medical Science Co., Ltd. (SHA:688013)

China · Delayed Price · Currency is CNY

24.15

-0.66 (-2.66%)

Oct 8, 2026, 2:04 PM CST

SHA:688013 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	283.9	326.73	272.37	253.65	232.03	213.74
Revenue Growth	-4.02%	19.96%	7.38%	9.31%	8.56%	30.85%
Gross Profit	180.6	208.2	158.73	141.85	132.23	122.47
Operating Income	42.37	72.18	46.34	29.58	33.27	28.41
Net Income	50.71	85.19	51.89	47.31	43.2	41.42
Earnings Per Share	0.63	1.05	0.64	0.58	0.53	0.51
EPS Growth	-27.78%	64.06%	10.35%	9.43%	3.92%	-5.56%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	211.59
Export	115.14
Total	326.73

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	252.09	294.01	395.12	430.05	362.34	430.91
Total Debt	130.96	50.46	2.02	1.96	0.96	-
Net Cash (Debt)	121.13	243.55	393.1	428.1	361.38	430.91
Net Cash Growth	-60.41%	-38.05%	-8.18%	18.46%	-16.14%	13.59%
Net Cash Per Share	1.50	3.00	4.85	5.25	4.43	5.31

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	41.84	71.99	53.41	82.95	50.4	60.98
Capital Expenditures	-73.79	-90.75	-41.94	-18.41	-47.67	-9.21
Free Cash Flow	-31.95	-18.76	11.47	64.54	2.73	51.77
Free Cash Flow Growth	-	-	-82.23%	2263.10%	-94.73%	48.80%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	63.61%	63.72%	58.28%	55.92%	56.99%	57.30%
Operating Margin	14.92%	22.09%	17.02%	11.66%	14.34%	13.29%
Pretax Margin	20.00%	29.13%	20.13%	18.90%	19.86%	21.57%
Profit Margin	17.86%	26.07%	19.05%	18.65%	18.62%	19.38%
FCF Margin	-11.25%	-5.74%	4.21%	25.44%	1.18%	24.22%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	1.600	1.300	1.000	-	0.250	0.200
Dividend Per Share Growth	-13.33%	30.00%	-	-	25.00%	0%
Dividend Yield	6.63%	2.79%	6.18%	-	1.46%	0.90%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	39.47	45.11	26.90	35.33	36.02	49.14
P/FCF Ratio	-	-	121.71	25.90	569.75	39.31
PS Ratio	7.00	11.76	5.13	6.59	6.71	9.52